1.The value of 2-D echocardiography in diagnosis of CHD.
Sang Kyung YUN ; Young Woon BAEK ; Hyun Ki JUNG
Journal of the Korean Pediatric Society 1991;34(5):662-667
No abstract available.
Diagnosis*
;
Echocardiography*
2.Giant Extra-Capsular Synovial Chondroma of the knee joint: A Case Report
Yak Woo ROH ; Byung Ki MOON ; Jung Il OH ; Kyung Chan LEE ; Woo Koo JUNG
The Journal of the Korean Orthopaedic Association 1981;16(1):178-181
Extra-capsular synovial chondroma is a rare condition in which metaplastic cartilaginous mass is formed by the cartilage nodule within the synovial connective tissue break through the joint capsule and continue to proliferate. The authors have experienced a case of giant extracapsular synovial chondroma, affecting the knee joint of 54 years old woman. A case of giant extra-capsular synovial chondroma is reported with brief review of literature.
Cartilage
;
Chondroma
;
Connective Tissue
;
Female
;
Humans
;
Joint Capsule
;
Knee Joint
;
Knee
3.Concurrent Medullay and Papillary Carcinoma of the Thyroid.
Seok Jun HONG ; Kyung Yub GONG ; Young Ki SONG ; Jin Sook RYU ; Ki Soo KIM ; Jung Hee LEE
Journal of Korean Society of Endocrinology 1998;13(4):634-639
The origins of medullary carcinoma and papillary carcinoma of thyroid are embryologically different. We report a case of simultaneous occurrence of medullary carcinoma and papillary carcinoma of the thyroid in the same thyroid gland. In this case, the occurrence of the two tumors may be a coincidence, does not have embryological or genetical significance.
Carcinoma, Medullary
;
Carcinoma, Papillary*
;
Thyroid Gland*
4.Decreased IgE antibody formation in mice treated with polyadenyic pollyuridylic acid and polyinosinic polycytidylic acid.
Bong Ki LEE ; Jeon Soo SHIN ; Min Kyung CHU ; Jung Koo YOUN
Journal of the Korean Society for Microbiology 1993;28(2):165-174
No abstract available.
Animals
;
Antibody Formation*
;
Immunoglobulin E*
;
Mice*
;
Poly I-C*
5.Enhancement of radiation effect using beta-lapachone and underlying mechanism.
Ki Jung AHN ; Hyung Sik LEE ; Se Kyung BAI ; Chang Won SONG
Radiation Oncology Journal 2013;31(2):57-65
Beta-lapachone (beta-Lap; 3,4-dihydro-2, 2-dimethyl-2H-naphthol[1, 2-b]pyran-5,6-dione) is a novel anti-cancer drug under phase I/II clinical trials. beta-Lap has been demonstrated to cause apoptotic and necrotic death in a variety of human cancer cells in vitro and in vivo. The mechanisms underlying the beta-Lap toxicity against cancer cells has been controversial. The most recent view is that beta-Lap, which is a quinone compound, undergoes two-electron reduction to hydroquinone form utilizing NAD(P)H or NADH as electron source. This two-electron reduction of beta-Lap is mediated by NAD(P)H:quinone oxidoreductase (NQO1), which is known to mediate the reduction of many quinone compounds. The hydroquinone forms of beta-Lap then spontaneously oxidizes back to the original oxidized beta-Lap, creating futile cycling between the oxidized and reduced forms of beta-Lap. It is proposed that the futile recycling between oxidized and reduced forms of beta-Lap leads to two distinct cell death pathways. First one is that the two-electron reduced beta-Lap is converted first to one-electron reduced beta-Lap, i.e., semiquinone beta-Lap (SQ).- causing production of reactive oxygen species (ROS), which then causes apoptotic cell death. The second mechanism is that severe depletion of NAD(P)H and NADH as a result of futile cycling between the quinone and hydroquinone forms of beta-Lap causes severe disturbance in cellular metabolism leading to apoptosis and necrosis. The relative importance of the aforementioned two mechanisms, i.e., generation of ROS or depletion of NAD(P)H/NADH, may vary depending on cell type and environment. Importantly, the NQO1 level in cancer cells has been found to be higher than that in normal cells indicating that beta-Lap may be preferentially toxic to cancer cells relative to non-cancer cells. The cellular level of NQO1 has been found to be significantly increased by divergent physical and chemical stresses including ionizing radiation. Recent reports clearly demonstrated that beta-Lap and ionizing radiation kill cancer cells in a synergistic manner. Indications are that irradiation of cancer cells causes long-lasting elevation of NQO1, thereby sensitizing the cells to beta-Lap. In addition, beta-Lap has been shown to inhibit the repair of sublethal radiation damage. Treating experimental tumors growing in the legs of mice with irradiation and intraperitoneal injection of beta-Lap suppressed the growth of the tumors in a manner more than additive. Collectively, beta-Lap is a potentially useful anti-cancer drug, particularly in combination with radiotherapy.
Animals
;
Apoptosis
;
Benzoquinones
;
Cell Death
;
Electrons
;
Humans
;
Hydroquinones
;
Injections, Intraperitoneal
;
Leg
;
Mice
;
NAD
;
Naphthoquinones
;
Necrosis
;
Radiation Tolerance
;
Radiation, Ionizing
;
Reactive Oxygen Species
;
Recycling
;
Substrate Cycling
6.The change of lymphocyte subpopulation of the thermal injured rats by exchange transfusion.
Ki Taek HAN ; Kyung Seul CHUNG ; Jung Gil CHUNG ; Sang Tae AHN ; Poong LIM
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1992;19(3):327-337
No abstract available.
Animals
;
Lymphocyte Subsets*
;
Lymphocytes*
;
Rats*
9.The long-term effect of captopril on steroid resistent nephrotic syndrome in children.
Jo Won JUNG ; Kyung Chong YU ; Ki Soo PAE ; Jae Seung LEE
Korean Journal of Nephrology 1991;10(2):150-156
No abstract available.
Captopril*
;
Child*
;
Humans
;
Nephrotic Syndrome*
10.The long-term effect of captopril on steroid resistent nephrotic syndrome in children.
Jo Won JUNG ; Kyung Chong YU ; Ki Soo PAE ; Jae Seung LEE
Korean Journal of Nephrology 1991;10(2):150-156
No abstract available.
Captopril*
;
Child*
;
Humans
;
Nephrotic Syndrome*